- Home
- LBPH vs GABC Comparison
LBPH vs GABC Comparison
Compare LBPH & GABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBPH
- GABC
- Stock Information
- Founded
- LBPH 2020
- GABC 1910
- Country
- LBPH United States
- GABC United States
- Employees
- LBPH N/A
- GABC N/A
- Industry
- LBPH Biotechnology: Pharmaceutical Preparations
- GABC Major Banks
- Sector
- LBPH Health Care
- GABC Finance
- Exchange
- LBPH Nasdaq
- GABC Nasdaq
- Market Cap
- LBPH 1.4B
- GABC 1.2B
- IPO Year
- LBPH 2021
- GABC N/A
- Fundamental
- Price
- LBPH $59.81
- GABC $45.08
- Analyst Decision
- LBPH Buy
- GABC Buy
- Analyst Count
- LBPH 8
- GABC 3
- Target Price
- LBPH $52.29
- GABC $44.33
- AVG Volume (30 Days)
- LBPH 834.8K
- GABC 94.1K
- Earning Date
- LBPH 11-07-2024
- GABC 10-28-2024
- Dividend Yield
- LBPH N/A
- GABC 2.40%
- EPS Growth
- LBPH N/A
- GABC N/A
- EPS
- LBPH N/A
- GABC 2.77
- Revenue
- LBPH N/A
- GABC $247,156,000.00
- Revenue This Year
- LBPH N/A
- GABC N/A
- Revenue Next Year
- LBPH N/A
- GABC $37.29
- P/E Ratio
- LBPH N/A
- GABC $16.22
- Revenue Growth
- LBPH N/A
- GABC N/A
- 52 Week Low
- LBPH $3.60
- GABC $27.23
- 52 Week High
- LBPH $59.95
- GABC $46.75
- Technical
- Relative Strength Index (RSI)
- LBPH 78.81
- GABC 62.20
- Support Level
- LBPH $59.47
- GABC $44.50
- Resistance Level
- LBPH $59.85
- GABC $46.33
- Average True Range (ATR)
- LBPH 0.20
- GABC 1.24
- MACD
- LBPH -0.84
- GABC -0.04
- Stochastic Oscillator
- LBPH 86.36
- GABC 75.51
About LBPH Longboard Pharmaceuticals Inc.
Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.
About GABC German American Bancorp Inc.
German American Bancorp Inc is a bank holding company. The Company's lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.